Optical coherence tomography in neuromyelitis optica

Archives of Neurology

Volumn 65, Issue 7, 2008, Pages 920-923

  De Seze, Jérôme ^a   Blanc, Frederic ^a   Jeanjean, Luc ^b   Zéphir, Hélène ^c   Labauge, Pierre ^b   Bouyon, Marie ^a   Ballonzoli, Laurent ^a   Castelnovo, Giovanni ^b   Fleury, Marie ^a   Defoort, Sabine ^c   Vermersch, Patrick ^c   Speeg, Claude ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b University of Nimes   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLINDNESS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE DURATION; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MYELOOPTIC NEUROPATHY; NERVE FIBER DEGENERATION; OPHTHALMOLOGY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; RETINA NERVE CELL; SCORING SYSTEM; VISION TEST; VISUAL ACUITY; VISUAL FIELD;

ADULT; AXONS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS;

EID: 47549095245     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.7.920     Document Type: Article

References (23)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology. 1999;53(5):1107-1114.
2. de Seze J, Stojkovic T, Ferriby D, et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci. 2002;197(1-2):57-61.
3. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? a comparative study with multiple sclerosis. Mult Scler. 2003;9(5):521-525.
4. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125(pt 7):1450-1461.
5. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-2112.
6. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473-477.
7. Weinshenker BG, Wingerchuk DM, Vukusic S, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566-569.
8. Matiello M, Jacob A, Pittock S, Lennon V, Weinshenker B. Recurrent optic neuritis: clinical and demographic features stratified by NMO-IgG seropositivity [abstract]. Neurology. 2007;68(suppl 1):A354.
9. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology. 1998;51(4):1219-1220.
10. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64(7):1270-1272.
11. Papeix C, Vidal JS, de Seze J, et al. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica. Mult Scler. 2007;13(2):256-259.
12. Frohman E, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol. 2006;5(10):853-863.
13. Kallenbach K, Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis. Eur J Neurol. 2007;14(8):841-849.
14. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnosis accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007;68(18):1488-1494.
15. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-1489.
16. de Seze J, Arndt C, Jeanjean L, et al. Relapsing inflammatory opticneuritis: is it neuromyelitis optica? Neurology. 2008;70(22):2075-2076.
17. Kurtzke JF. Rating neurologic impairment in multiple sclerosis. Neurology. 1983;33(11):1444-1452.
18. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol. 2005;58(3):383-391.
19. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113(2):324-332.
20. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59(6):963-969.
21. Li Q, Timmers AM, Hunter K, et al. Non-invasive imaging by optical coherence tomography to monitor retinal degeneration in the mouse. Invest Ophthalmol Vis Sci. 2001;42(12):2981-2989.
22. Horio N, Kachi S, Hori K, et al. Progressive change of optical coherence tomography scans in retinal degeneration slow mice. Arch Ophthalmol. 2001;119(9):1329-1332.
23. Grieve K, Paques M, Dubois A, Sahel J, Boccara C, Le Gargasson JF. Ocular tissue imaging using ultrahigh-resolution, full-field optical coherence tomography. Invest Ophthalmol Vis Sci. 2004;45(11):4126-4131.